Form 4 for GUTS FRACTYL HEALTH, INC.
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-10 · accession 0000950170-24-126558 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-13 | 2024-11-11 | GUTS | Caplan Jay David | Pres, Chief Product Off | S - Sale+OE | $2.47 | -64.2K | 153.5K | -29% | -$158.6K |
| D | 2024-11-13 | 2024-11-10 | GUTS | Caplan Jay David | Pres, Chief Product Off | M - OptEx | $0.00 | +187.3K | 217.7K | +614% | $0 |
| D | 2024-11-13 | 2024-11-10 | GUTS | Caplan Jay David | Pres, Chief Product Off | M - OptEx | $0.00 | -187.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-11 | S | D | 64,197 | $2.47 | 153,544 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-10 | M | A | 187,257 | $0.00 | 217,741 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. |
| 3 | Derivative | Restricted Stock Unit | 2024-11-10 | M | D | 187,257 | $0.00 | 0 | D | — · — to — | 187,257 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. |